Apgar, James M <br/><br/>
Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin.  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  Dec 2015 
 - 5813-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1464-3405 
<br/><br/><label>Standard No.: </label>10.1016/j.bmcl.2015.10.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antifungal Agents--chemistry<br/>Aspergillus fumigatus--drug effects<br/>Candida albicans--drug effects<br/>Candidiasis--drug therapy<br/>Glucosyltransferases--antagonists & inhibitors<br/>Glycosides--chemistry<br/>Half-Life<br/>Mice<br/>Microbial Sensitivity Tests<br/>Structure-Activity Relationship<br/>Terpenes--chemistry<br/>Triterpenes--chemistry<br/>beta-Glucans--chemistry